AMF Concludes its Review of the Refinancing Transactions Completed by Liminal BioSciences in April 2019

By In The News
November 28, 2019 in The Headlines

Recommended Posts

In The News

Posted November 28, 2019

- Share

Posted November 28, 2019

LAVAL, QC, ROCKVILLE, MD and CAMBRIDGE, United Kingdom, Nov. 28, 2019 /PRNewswire/ - Liminal BioSciences Inc. (NASDAQ: LMNL) (TSX: LMNL) ( "Liminal BioSciences" or the "Company" ), a clinical-stage biopharmaceutical company focused on developing novel therapeutics to treat unmet needs in...

View the full article

Link to comment

Share on other sites

Archived

This topic is now archived and is closed to further replies.

Go to topic listing

Most Contributions
1. In The News
  221741
2. Jaydee
  17628
3. deicer
  13180
4. Kip Powick
  12287
5. dagger
  9605
Tell a friend
Love The Airline Website? Tell a friend!
- Email
- Share
Forum Statistics
- Total Topics
  
  272.1k
- Total Posts
  
  564k

Sign In

AMF Concludes its Review of the Refinancing Transactions Completed by Liminal BioSciences in April 2019

Recommended Posts

In The News

Link to comment

Share on other sites

Archived

Most Contributions

Tell a friend

Forum Statistics

Browse

Activity

Support